Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Progressive Spinal Technologies was a medical device company specializing in the development of advanced spinal surgery technologies. The company focused on creating innovative systems for the treatment of complex spinal deformities and degenerative conditions. Its primary contribution to the field was the HELIOS system, a dynamic stabilization technology intended to improve outcomes in scoliosis surgery. Founded by Dr. Thomas Errico, the company was acquired by K2M Group Holdings in 2014. Following Stryker's acquisition of K2M in 2018, the technologies developed by Progressive Spinal Technologies were integrated into Stryker's spine portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Progressive Spinal Technologies.